Evidence map›Paper›PMID 36200950›Full record

ArticleClinical and experimental immunology2022

Stratification of alopecia areata reveals involvement of CD4 T cell populations and altered faecal microbiota.

K A Bain, B Nichols, F Moffat, C Kerbiriou, U Z Ijaz, K Gerasimidis, I B McInnes, A Åstrand, S Holmes, S W F Milling

Open access · hybridAbstract read
In one paragraph

Article in Clinical and experimental immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. International journal of molecular sciences · 2025
    Article
  4. Cutaneous and Gut Dysbiosis in Alopecia Areata: A Review.JID innovations : skin science from molecules to population health · 2025
    Review
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

K A BainInstitute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, UK.
B NicholsHuman Nutrition, New Lister Building, University of Glasgow, Glasgow Royal Infirmary, Glasgow, UK.
F MoffatAlan Lyell Centre for Dermatology, Queen Elizabeth University Hospital, Glasgow, UK.
C KerbiriouHuman Nutrition, New Lister Building, University of Glasgow, Glasgow Royal Infirmary, Glasgow, UK.
U Z IjazDepartment of Infrastructure and Environment, University of Glasgow, Glasgow, UK.
K GerasimidisHuman Nutrition, New Lister Building, University of Glasgow, Glasgow Royal Infirmary, Glasgow, UK.ORCID 0000-0001-9432-2200
I B McInnesInstitute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, UK.
A ÅstrandLate Phase Development, Respiratory, Immunology & Infection, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
S HolmesAlan Lyell Centre for Dermatology, Queen Elizabeth University Hospital, Glasgow, UK.
S W F MillingInstitute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, UK.ORCID 0000-0003-4384-5516
University of Glasgow · GBGlasgow Royal Infirmary · GBQueen Elizabeth University Hospital · GBAstraZeneca (Sweden) · SE

Funding

Chief Scientist Office TCS/20/10
6 · The paper itself

Abstract

Alopecia areata (AA) is an immune-mediated disease that causes non-scarring hair loss. Autoreactive CD8 T cells are key pathogenic effectors in the skin, and AA has been associated both with atopy and with perturbations in intestinal homeostasis. This study aimed to investigate mechanisms driving AA by characterizing the circulating immunophenotype and faecal microbiome, and by stratifying AA to understand how identified signatures associated with heterogeneous clinical features of the condition. Flow cytometric analyses identified alterations in circulating B cells and CD4 T cells, while 16S sequencing identified changes in alpha and beta diversity in the faecal microbiome in AA. The proportions of transitional and naïve B cells were found to be elevated in AA, particularly in AA samples from individuals with >50% hair loss and those with comorbid atopy, which is commonly associated with extensive hair loss. Although significant changes in circulating CD8 T cells were not observed, we found significant changes in CD4+ populations. In individuals with <50% hair loss higher frequencies of CCR6+CD4 ("Th17") and CCR6+CXCR3+CD4 ("Th1/17") T cells were found. While microbial species richness was not altered, AA was associated with reduced evenness and Shannon diversity of the intestinal microbiota, again particularly in those with <50% hair loss. We have identified novel immunological and microbial signatures in individuals with alopecia areata. Surprisingly, these are associated with lower levels of hair loss, and may therefore provide a rationale for improved targeting of molecular therapeutics.

Indexed as

Alopecia AreataMicrobiotaCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesHumansautoimmunitymicrobiomeskinT cells

Identifiers

PMID36200950
PMCPMC9750826
OpenAlexW4302761496

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.